Phase
Condition
N/ATreatment
Azithromycin for Oral Suspension
Clinical Study ID
Ages 1-59 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
CSI-level for mortality and AMR monitoring:
Located in a region participating in the program
Designated as rural by local study team
Selected for participation in monitoring activities
Safe and accessible for study teams
Verbal approval from community leaders
Individual level for mortality monitoring:
Residing in the catchment area of an eligible CSI
Selected for participation in monitoring activities
Female
Age between 12 and 55 years old
Verbal approval from participant
Individual-level for AMR monitoring:
Residing in the catchment area of an eligible CSI
Selected for participation in monitoring activities
Age between 1 and 59 months old
Verbal approval from a caregiver or guardian
Exclusion
Exclusion Criteria:
At the community-level:
Designated as urban by local study team
Inaccessible or unsafe for study team
At the individual-level:
- Known allergy to macrolides
Study Design
Study Description
Connect with a study center
Program National de Santé Oculaire
Niamey,
NigerActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.